Palatin Technologies, Inc. (PTN)
22.52
-0.98
(-4.17%)
USD |
NYAM |
Mar 16, 16:00
Palatin Technologies EPS Diluted (Quarterly) : -2.860 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.264M |
| Revenue (Quarterly) | 0.116M |
| Total Expenses (Quarterly) | 7.380M |
| Enterprise Value | 6.807M |
| Gross Profit Margin (Quarterly) | 87.59% |
| Profit Margin (Quarterly) | -6.26K% |
| Earnings Yield | -5.25% |
| Normalized Earnings Yield | -5.255 |